Cargando…

Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination

PURPOSE: We compared the performance of an in-house-developed flow cytometry assay for intracellular cytokine staining (FC-ICS) and a commercially-available cytokine release assay (the QuantiFERON® SARS-CoV-2 Test [QF]) for detection and quantification of SARS-CoV-2-Spike (S)-reactive-IFN-γ-producin...

Descripción completa

Detalles Bibliográficos
Autores principales: Tormo, Nuria, Giménez, Estela, Martínez-Navarro, María, Albert, Eliseo, Navalpotro, David, Torres, Ignacio, Gimeno, Concepción, Navarro, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853233/
https://www.ncbi.nlm.nih.gov/pubmed/35165804
http://dx.doi.org/10.1007/s10096-022-04422-7
_version_ 1784653190113787904
author Tormo, Nuria
Giménez, Estela
Martínez-Navarro, María
Albert, Eliseo
Navalpotro, David
Torres, Ignacio
Gimeno, Concepción
Navarro, David
author_facet Tormo, Nuria
Giménez, Estela
Martínez-Navarro, María
Albert, Eliseo
Navalpotro, David
Torres, Ignacio
Gimeno, Concepción
Navarro, David
author_sort Tormo, Nuria
collection PubMed
description PURPOSE: We compared the performance of an in-house-developed flow cytometry assay for intracellular cytokine staining (FC-ICS) and a commercially-available cytokine release assay (the QuantiFERON® SARS-CoV-2 Test [QF]) for detection and quantification of SARS-CoV-2-Spike (S)-reactive-IFN-γ-producing T cells after COVID-19 vaccination. PATIENTS AND METHODS: The sample included 141 individuals (all male; median age, 42 years; 20–72) who had been fully vaccinated with the Comirnaty® COVID-19 vaccine (at a median of 114 days; 34–145). Prior to vaccination, 91 were categorized as being SARS-CoV-2-naïve and 50 as SARS-CoV-2-experienced. A whole blood-based FC-ICS using 15-mer overlapping peptides encompassing the entire SARS-CoV-2 S protein was used for enumeration of virus-specific IFN-γ-producing CD4(+) and CD8(+) T cells. The QF test (Ag1 for CD4(+) T cells and Ag2 for CD4(+) and CD8(+) T cells in combination) was carried out following the manufacturer’s instructions. RESULTS: The FC-ICS and the QF assays returned significantly discordant qualitative results in both the entire cohort (P<0.001 with QF Ag1 and QF Ag2) and in SARS-CoV-2-naïve participants alone (P=0.005 and P=0.01, respectively). Discrepant results mostly involved FC-ICS positive/QF negative specimens. Overall, no correlation was found either between SARS-CoV-2 IFN-γ- CD4(+) T-cell frequencies and IFN-γ levels measured in the QF Ag1 tube (P=0.78) or between the sum of SARS-CoV-2 IFN-γ CD4(+) and CD8(+) T-cell frequencies and IFN-γ levels quantified in the QF Ag2 tube. CONCLUSION: The data suggest a greater sensitivity for the FC-ICS assay than the QF test, and urge caution when comparing SARS-CoV-2 T-cell immune responses assessed using different analytical platforms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10096-022-04422-7.
format Online
Article
Text
id pubmed-8853233
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88532332022-02-18 Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination Tormo, Nuria Giménez, Estela Martínez-Navarro, María Albert, Eliseo Navalpotro, David Torres, Ignacio Gimeno, Concepción Navarro, David Eur J Clin Microbiol Infect Dis Original Article PURPOSE: We compared the performance of an in-house-developed flow cytometry assay for intracellular cytokine staining (FC-ICS) and a commercially-available cytokine release assay (the QuantiFERON® SARS-CoV-2 Test [QF]) for detection and quantification of SARS-CoV-2-Spike (S)-reactive-IFN-γ-producing T cells after COVID-19 vaccination. PATIENTS AND METHODS: The sample included 141 individuals (all male; median age, 42 years; 20–72) who had been fully vaccinated with the Comirnaty® COVID-19 vaccine (at a median of 114 days; 34–145). Prior to vaccination, 91 were categorized as being SARS-CoV-2-naïve and 50 as SARS-CoV-2-experienced. A whole blood-based FC-ICS using 15-mer overlapping peptides encompassing the entire SARS-CoV-2 S protein was used for enumeration of virus-specific IFN-γ-producing CD4(+) and CD8(+) T cells. The QF test (Ag1 for CD4(+) T cells and Ag2 for CD4(+) and CD8(+) T cells in combination) was carried out following the manufacturer’s instructions. RESULTS: The FC-ICS and the QF assays returned significantly discordant qualitative results in both the entire cohort (P<0.001 with QF Ag1 and QF Ag2) and in SARS-CoV-2-naïve participants alone (P=0.005 and P=0.01, respectively). Discrepant results mostly involved FC-ICS positive/QF negative specimens. Overall, no correlation was found either between SARS-CoV-2 IFN-γ- CD4(+) T-cell frequencies and IFN-γ levels measured in the QF Ag1 tube (P=0.78) or between the sum of SARS-CoV-2 IFN-γ CD4(+) and CD8(+) T-cell frequencies and IFN-γ levels quantified in the QF Ag2 tube. CONCLUSION: The data suggest a greater sensitivity for the FC-ICS assay than the QF test, and urge caution when comparing SARS-CoV-2 T-cell immune responses assessed using different analytical platforms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10096-022-04422-7. Springer Berlin Heidelberg 2022-02-15 2022 /pmc/articles/PMC8853233/ /pubmed/35165804 http://dx.doi.org/10.1007/s10096-022-04422-7 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Tormo, Nuria
Giménez, Estela
Martínez-Navarro, María
Albert, Eliseo
Navalpotro, David
Torres, Ignacio
Gimeno, Concepción
Navarro, David
Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination
title Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination
title_full Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination
title_fullStr Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination
title_full_unstemmed Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination
title_short Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination
title_sort performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the quantiferon® sars-cov-2 test for detection and quantification of sars-cov-2-spike-reactive-ifn-γ-producing t cells after covid-19 vaccination
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853233/
https://www.ncbi.nlm.nih.gov/pubmed/35165804
http://dx.doi.org/10.1007/s10096-022-04422-7
work_keys_str_mv AT tormonuria performancecomparisonofaflowcytometryimmunoassayforintracellularcytokinestainingandthequantiferonsarscov2testfordetectionandquantificationofsarscov2spikereactiveifngproducingtcellsaftercovid19vaccination
AT gimenezestela performancecomparisonofaflowcytometryimmunoassayforintracellularcytokinestainingandthequantiferonsarscov2testfordetectionandquantificationofsarscov2spikereactiveifngproducingtcellsaftercovid19vaccination
AT martineznavarromaria performancecomparisonofaflowcytometryimmunoassayforintracellularcytokinestainingandthequantiferonsarscov2testfordetectionandquantificationofsarscov2spikereactiveifngproducingtcellsaftercovid19vaccination
AT alberteliseo performancecomparisonofaflowcytometryimmunoassayforintracellularcytokinestainingandthequantiferonsarscov2testfordetectionandquantificationofsarscov2spikereactiveifngproducingtcellsaftercovid19vaccination
AT navalpotrodavid performancecomparisonofaflowcytometryimmunoassayforintracellularcytokinestainingandthequantiferonsarscov2testfordetectionandquantificationofsarscov2spikereactiveifngproducingtcellsaftercovid19vaccination
AT torresignacio performancecomparisonofaflowcytometryimmunoassayforintracellularcytokinestainingandthequantiferonsarscov2testfordetectionandquantificationofsarscov2spikereactiveifngproducingtcellsaftercovid19vaccination
AT gimenoconcepcion performancecomparisonofaflowcytometryimmunoassayforintracellularcytokinestainingandthequantiferonsarscov2testfordetectionandquantificationofsarscov2spikereactiveifngproducingtcellsaftercovid19vaccination
AT navarrodavid performancecomparisonofaflowcytometryimmunoassayforintracellularcytokinestainingandthequantiferonsarscov2testfordetectionandquantificationofsarscov2spikereactiveifngproducingtcellsaftercovid19vaccination